Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Moberg Pharma Max Drawdown (5Y) : 90.00% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 90.00% |
| June 30, 2026 | 90.00% |
| May 31, 2026 | 90.00% |
| April 30, 2026 | 90.00% |
| March 31, 2026 | 90.00% |
| February 28, 2026 | 90.00% |
| January 31, 2026 | 90.00% |
| December 31, 2025 | 90.00% |
| November 30, 2025 | 90.00% |
| October 31, 2025 | 90.00% |
| September 30, 2025 | 90.00% |
| August 31, 2025 | 90.00% |
| July 31, 2025 | 90.00% |
| June 30, 2025 | 90.00% |
| May 31, 2025 | 90.00% |
| April 30, 2025 | 90.00% |
| March 31, 2025 | 90.00% |
| February 28, 2025 | 90.00% |
| January 31, 2025 | 89.27% |
| December 31, 2024 | 89.11% |
| November 30, 2024 | 87.92% |
| October 31, 2024 | 87.92% |
| September 30, 2024 | 87.45% |
| August 31, 2024 | 80.67% |
| July 31, 2024 | 80.67% |
| Date | Value |
|---|---|
| June 30, 2024 | 80.67% |
| May 31, 2024 | 80.67% |
| April 30, 2024 | 80.67% |
| March 31, 2024 | 80.67% |
| February 29, 2024 | 80.67% |
| January 31, 2024 | 80.67% |
| December 31, 2023 | 80.67% |
| November 30, 2023 | 80.67% |
| October 31, 2023 | 80.67% |
| September 30, 2023 | 80.67% |
| August 31, 2023 | 80.67% |
| July 31, 2023 | 80.67% |
| June 30, 2023 | 80.67% |
| May 31, 2023 | 80.67% |
| April 30, 2023 | 80.67% |
| March 31, 2023 | 80.67% |
| February 28, 2023 | 80.67% |
| January 31, 2023 | 80.67% |
| December 31, 2022 | 80.67% |
| November 30, 2022 | 80.67% |
| October 31, 2022 | 80.67% |
| September 30, 2022 | 80.67% |
| August 31, 2022 | 80.67% |
| July 31, 2022 | 80.67% |
| June 30, 2022 | 80.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Orexo AB | 86.49% |
| Swedencare AB | -- |
| Camurus AB | 27.76% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 27.87% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -7.360 |
| Beta (5Y) | -0.1945 |
| Historical Sortino (5Y) | -0.1435 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.85% |